Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03VPC
|
||||
Former ID |
DAP000191
|
||||
Drug Name |
Cilostazol
|
||||
Synonyms |
Cilostazole; Cilostazolum; Pletaal; Pletal; Otsuka brand of cilostazol; C 0737; CL23867; OPC 13013; OPC 21; Cilostazol [INN:JAN]; Cilostazolum [INN-Latin]; OPC-13013; OPC-21; Pleta (TN); Pletal (TN); Pletal, Cilostazol; Cilostazol (JP15/USAN/INN); 3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone; 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one; 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Vasodilator Agents
|
||||
Company |
Otsuka Pharmaceutical Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H27N5O2
|
||||
InChI |
InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
|
||||
InChIKey |
RRGUKTPIGVIEKM-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 73963-72-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
855683, 6897916, 7848958, 7978527, 8151779, 11110906, 11113335, 11372358, 11374323, 11484992, 11488934, 11490985, 11492587, 11528739, 12012700, 14755273, 14828756, 17404781, 24278291, 26612838, 26680450, 26719653, 26719654, 26746958, 26746959, 29221909, 46386747, 46386994, 46506317, 47365365, 48259412, 48259413, 49834949, 50100194, 50103999, 50104000, 50409718, 53777324, 53787948, 56422089, 56463107, 57321435, 68530811, 85230957, 85787626, 87218800, 87218801, 87219014, 90341176, 92124839
|
||||
SuperDrug ATC ID |
B01AC23
|
||||
Target and Pathway | |||||
Target(s) | Phosphodiesterase (PDE) 3 | Target Info | Modulator | [556264] | |
References | |||||
Ref 536186 | Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90. | ||||
Ref 542155 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7148). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.